| Management number | 232054914 | Release Date | 2026/06/18 | List Price | $57.66 | Model Number | 232054914 | ||
|---|---|---|---|---|---|---|---|---|---|
| Category | |||||||||
This issue of Current Topics in Behavioral Neuroscience focuses on the neuropeptide orexin (hypocretin) and brings together scientists from around the world who will provide a timely discussion of how this peptide regulates behavior. This is a fast-moving field, and with the incorporation of novel technologies, new breakthroughs are likely to continue. For example, the use of optogenetic approaches has enabled the identification of the role of orexin-containing neurons in arousal states, critical for higher order functioning. From a clinical perspective, genetic polymorphisms in hypocretin/orexin and orexin receptors are implicated in a number of psychiatric disorders. In addition, advanced clinical trials are currently underway for orexin receptor antagonists in the treatment of insomnia and sleep disorders. We aim to capture a broad audience of basic scientists and clinicians. Read more
| ASIN | B0714QX1R6 |
|---|---|
| XRay | Not Enabled |
| ISBN13 | 978-3319575353 |
| Edition | 1st ed. 2017 |
| Language | English |
| File size | 16.1 MB |
| Page Flip | Enabled |
| Publisher | Springer |
| Word Wise | Not Enabled |
| Print length | 334 pages |
| Accessibility | Learn more |
| Screen Reader | Supported |
| Part of series | Current Topics in Behavioral Neurosciences |
| Publication date | May 29, 2017 |
| Enhanced typesetting | Enabled |
If you notice any omissions or errors in the product information on this page, please use the correction request form below.
Correction Request Form